Organ-specific management and supportive care in chronic graft-versus-host disease

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Chronic graft-versus-host disease (cGvHD) is a significant complication following allogeneic stem cell transplantation.
• Organ-specific manifestations of cGvHD require tailored management strategies.
• Effective supportive care is crucial for improving patient outcomes.

Purpose of the Study:

• To provide evidence-based recommendations for the management of organ-specific complications of cGvHD.
• To outline supportive care strategies, including infection prophylaxis and vaccinations.
• To guide clinicians in balancing cGvHD control with treatment toxicity.

Main Methods:

• A joint working group reviewed available literature on cGvHD management.
• Recommendations were developed for specific organ manifestations (skin, oral, liver, gut, lung, ocular, genital).
• Guidelines address supportive care, including vaccinations and infection prophylaxis.

Main Results:

• The guideline details specific therapies for various cGvHD manifestations.
• Recommendations for supportive care aim to minimize toxicity and relapse risk.
• The focus is on effective control of cGvHD.

Conclusions:

• This guideline provides a comprehensive framework for managing cGvHD complications.
• Adherence to these recommendations can optimize patient care and outcomes.
• It emphasizes a balanced approach to treatment, prioritizing patient safety and disease control.